MEI PHARMA INC's ticker is MEIP and the CUSIP is 55279B202. A total of 81 filers reported holding MEI PHARMA INC in Q1 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $650,000 | -22.2% | 360,977 | +0.9% | 0.00% | – |
| Q4 2021 | $835,000 | -21.3% | 357,643 | -9.3% | 0.00% | – |
| Q3 2021 | $1,061,000 | 0.0% | 394,161 | +5.9% | 0.00% | – |
| Q2 2021 | $1,061,000 | -22.3% | 372,088 | -6.5% | 0.00% | – |
| Q1 2021 | $1,365,000 | +27.9% | 397,754 | -1.6% | 0.00% | – |
| Q4 2020 | $1,067,000 | -15.2% | 404,297 | +0.3% | 0.00% | – |
| Q3 2020 | $1,258,000 | -77.3% | 403,028 | -69.9% | 0.00% | -100.0% |
| Q2 2020 | $5,539,000 | +1573.4% | 1,341,047 | +551.8% | 0.00% | – |
| Q1 2020 | $331,000 | -23.0% | 205,731 | +18.6% | 0.00% | – |
| Q4 2019 | $430,000 | +46.3% | 173,516 | -1.0% | 0.00% | – |
| Q3 2019 | $294,000 | -32.9% | 175,232 | 0.0% | 0.00% | – |
| Q2 2019 | $438,000 | – | 175,232 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TLS Advisors LLC | 2,010,285 | $490 | 2.42% |
| Anson Funds Management LP | 10,617,959 | $2,586,535 | 0.43% |
| NEA Management Company, LLC | 8,533,072 | $2,078,656 | 0.12% |
| Boxer Capital, LLC | 2,913,091 | $709,629 | 0.04% |
| Investmark Advisory Group LLC | 136,000 | $33,130 | 0.02% |
| CARLSON CAPITAL L P | 1,180,000 | $287,448 | 0.02% |
| Mesirow Financial Investment Management, Inc. | 20,486 | $4,990 | 0.02% |
| Artal Group S.A. | 1,000,000 | $244 | 0.01% |
| Annandale Capital, LLC | 100,000 | $24 | 0.01% |
| ACADIAN ASSET MANAGEMENT LLC | 4,758,364 | $1,158 | 0.01% |